Gautier Koscielny | Scientific Leader, GSK, Open Targets
Gautier Koscielny is a computational biologist at GSK and one of the bioinformatics platform leads for Open Targets. His main interest is to strengthen the understanding of biological processes that underlie human diseases by working on open initiatives with the scientific community.
Prior to joining GSK, he led a bioinformatics team at the EMBL-EBI involved in the NIH KOMP2 project and the International Mouse Phenotyping Consortium (IMPC) to integrate, analyse and mine complex phenotypic data. He developed and maintained bioinformatics pipelines to consolidate genomic information on vertebrate and non-vertebrate species in Ensembl and Ensembl Genomes.
|Part 1: Educating on the open targets platform|
Open Targets is an innovative, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.
Visit the Open Targets Platform which provides an integration of public domain data to enable target identification and prioritisation.
Generating and interpreting the data required to identify a good drug target demands a diverse set of skills, backgrounds, evidence types and technologies, which do not exist today in any single entity. Open Targets brings together expertise from four complementary institutions to systematically identify and prioritise targets from which safe and effective medicines can be developed.
Our goals are to:
Integrating your expertise and AI approaches into the Open Targets platform